Abstract 1571
Background
The aim of the EDIFICE surveys is to improve insight into screening programs in France. We hypothesized that individual opinions may affect physicians' and laypersons' attitudes toward prescribing or participating in screening, respectively; we assessed physicians' and laypersons' opinions, focusing on colorectal (CRC), breast (BC), cervical (CC), prostate (PC) and lung (LC) cancer screening.
Methods
The 4th nationwide observational survey was conducted by phone interviews using the quota method. A representative sample of 1463 individuals with no history of cancer (age 40-75 y; 726 men [m], 737 women [w]) was interviewed from 12 June-10 July 2014. A mirror survey on a representative sample of 301 physicians (201 general practitioners [GP, 131 m, 70 w] and 100 oncologists [65 m, 35 w]) was conducted from 9 July-8 August. We analyzed replies stating screening to be more reassuring than worrying.
Results
In general, screening was more reassuring than worrying, more so for physicians than for laypersons (CRC 65% vs 51%, CC 74% vs 62%, PC 59% vs 43%, P
Conclusions
Physicians tend to be more reassured by screening than laypersons, and oncologists more so than GP, with the exception of PC screening. The official guidelines for CRC and BC screening are a good setting for GPs' medical practice. The most widely used screening programs (CRC, BC, PC) enable GP to make objective prescriptions, regardless of individual opinions. In the absence of guidelines (PC), prescription rates are correlated with physicians' confidence in screening. Reassurance in screening has a positive impact on laypersons' participation rates.
Clinical trial identification
Legal entity responsible for the study
EDIFICE surveys are funded by Roche
Funding
EDIFICE surveys are funded by Roche
Disclosure
Jean F. Morère,Sébastien Couraud, Jean-Yves Blay, Alexis B. Cortot, Laurent Greillier, Xavier B. Pivot, François Eisinger: Honorarium fees from Roche. C. Lhomel: Employee of Roche.
All other authors have declared no conflicts of interest.
Resources from the same session
ZUMA-3: A phase 1/2 multi-center study evaluation the safety and efficacy of KTE-C19 anti-CD19 CAR T cells in adult patients with relapsed/refractory B precursor acute lymphoblastic leukemia (R/R ALL)
Presenter: Bijal Shah
Session: Poster display
Resources:
Abstract
ZUMA-2: A phase 2 multi-center study evaluating the efficacy of KTE-C19 (Anti-CD19 CAR T cells) in patients with relapsed/refractory Mantle cell lymphoma (R/R MCL)
Presenter: Michael Wang
Session: Poster Display
Resources:
Abstract
ZUMA-1: A phase 2 multi-center study evaluating anti-CD19 chimeric antigen receptor (CAR) T cells in patients with refractory aggressive non-Hodgkin lymphoma (NHL)
Presenter: Sattva Neelapu
Session: Poster Display
Resources:
Abstract
Younger age as a prognostic indicator in breast cancer: Correlation between clinical-pathologic factors and miRNAs and long-term follow-up
Presenter: Maria Teresa Martinez
Session: Poster display
Resources:
Abstract
Window study of the PARP inhibitor rucaparib in patients with primary triple negative or BRCA1/2 related breast cancer (RIO)
Presenter: Christy Toms
Session: Poster display
Resources:
Abstract
Whole exome sequencing (WES) and RNA sequencing (RNA-seq) in routine clinical practice for colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) patients (pts)
Presenter: Géraldine Perkins
Session: Poster display
Resources:
Abstract
What is the optimal annual interpretive volume for a radiologist reading screening mammograms?
Presenter: Asli Uluturk
Session: Poster display
Resources:
Abstract
What decides breast conservation versus mastectomy in the background of diverse sociocultural environment, an Indian study
Presenter: Poonamalle Padmanabhan Bapsy
Session: Poster display
Resources:
Abstract
Waiting time to diagnosis and treatment of the head and neck cancer in four institutions in Portugal
Presenter: Ana Castro
Session: Poster display
Resources:
Abstract
Wait times for diagnosis and treatment of lung cancer: a single centre experience
Presenter: Catherine Labbe
Session: Poster Display
Resources:
Abstract